NovaBridge Biosciences NBP
NASDAQ NBP
$1.80 +0.00 (+0.00%)
At close: Sep 4, 2026 · 4:00 PM EDT

NovaBridge Biosciences (NBP) Prepaid Assets (2018 - 2026)

NovaBridge Biosciences (NBP) posted quarterly Prepaid Assets of $6.7 million for Q4 2025, up 102.67% year-over-year from $3.3 million in Q4 2024, and up 48.37% quarter-over-quarter from $4.5 million in Q3 2025.

Analysis

NovaBridge Biosciences (NBP) Prepaid Assets (2018 - 2026) Analysis & Trends

NovaBridge Biosciences (NBP) has reported Prepaid Assets for 8 consecutive years, with $6.7 million the latest figure, recorded in Q4 2025.

  • In Q4 2025, Prepaid Assets rose 102.67% year-over-year to $6.7 million; the TTM figure through Dec 2025 stood at $6.7 million (up 102.67% YoY), while the FY2025 annual figure was $6.7 million, up 102.67% from the prior year.
  • Prepaid Assets rose to $6.7 million in Q4 2025 per NBP's latest filing, from $4.5 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $29.8 billion in Q4 2021 and bottomed at $2.0 million in Q2 2025.
  • Historically, Prepaid Assets has averaged $2.3 billion across 5 years, with a median of $7.2 million in 2023.
  • Annual changes were most pronounced in 2021 — Prepaid Assets jumped 101093.59% — and 2022, when it plunged 99.96%.
  • NovaBridge Biosciences' Prepaid Assets stood at $29.8 billion in 2021, then slumped by 99.96% to $11.3 million in 2022, then slumped by 36.01% to $7.2 million in 2023, then tumbled by 54.38% to $3.3 million in 2024, then soared by 102.67% to $6.7 million in 2025.
  • Business Quant data shows NBP's Prepaid Assets at $6.7 million in Q4 2025, $4.5 million in Q3 2025, and $2.0 million in Q2 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 NovaBridge Biosciences 197.68 Mn 197.68 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.16 Mn
Dec 31, 2025 6.68 Mn
Sep 30, 2025 4.50 Mn
Jun 30, 2025 2.03 Mn
Mar 31, 2025 4.61 Mn
Dec 31, 2024 3.30 Mn
Sep 30, 2024 3.82 Mn
Jun 30, 2024 22.99 Mn
Dec 31, 2023 7.22 Mn
Jun 30, 2023 14.11 Mn
Dec 31, 2022 11.29 Mn
Jun 30, 2022 15.08 Mn
Dec 31, 2021 29.85 Mn
Jun 30, 2021 31.04 Mn
Dec 31, 2020 29.49 Mn
Sep 30, 2020 32.38 Mn
Jun 30, 2020 18.56 Mn
Dec 31, 2019 19.30 Mn
Dec 31, 2018 12.87 Mn